Medroxyprogesterone Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 18 USDMF, 7 CEP/COS, 1 JDMF, 5 KDMF, 16 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

154 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 22 Australia, 17 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 30 Direct Compression, 28 Coating Systems & Additives, 26 Solubilizers, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 18 Granulation, 17 Parenteral, 16 Co-Processed Excipients, 16 Topical, 11 Disintegrants & Superdisintegrants, 11 Film Formers & Plasticizers, 11 Taste Masking, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Finished Drug Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 12541 / DOSAGE - INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MEDROXYPROGESTERONE ACETATE(UNII: C2QI4IOI2G) (MEDROXYPROGESTERONE - UNII:HSU1C9YRES)	MEDROXYPROGESTERONE ACETATE	400mg in 1

Inactive Ingredients

Ingredient Name	Pharmacia and Upjohn Company LLC
HYDROCHLORIC ACID(QTT17582CB)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
SODIUM HYDROXIDE(55X04QC32I)
SODIUM SULFATE ANHYDROUS(36KCS0R750)

Drug Product Composition: Medroxyprogesterone Acetate